Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...
ET Now on MSN6d
Agilus Diagnostics, India’s leading diagnostic network, has emerged as a trusted name in the industry, securing rank 1 in the Times Diagnostic Survey.
The company introduced technologies like Next-Generation Sequencing and Sanger Sequencing nearly a decade ago.